Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Gross Profit (2016 - 2025)

Historic Gross Profit for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $228.1 million.

  • Healthequity's Gross Profit rose 1575.27% to $228.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $874.0 million, marking a year-over-year increase of 1629.68%. This contributed to the annual value of $777.3 million for FY2025, which is 2483.34% up from last year.
  • As of Q4 2025, Healthequity's Gross Profit stood at $228.1 million, which was up 1575.27% from $232.6 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's Gross Profit peaked at $232.6 million during Q3 2025, and registered a low of $100.9 million during Q1 2021.
  • Over the past 5 years, Healthequity's median Gross Profit value was $150.1 million (recorded in 2023), while the average stood at $155.1 million.
  • As far as peak fluctuations go, Healthequity's Gross Profit tumbled by 1122.7% in 2021, and later soared by 3454.13% in 2024.
  • Over the past 5 years, Healthequity's Gross Profit (Quarter) stood at $103.6 million in 2021, then grew by 22.93% to $127.3 million in 2022, then grew by 25.03% to $159.2 million in 2023, then rose by 23.77% to $197.0 million in 2024, then increased by 15.75% to $228.1 million in 2025.
  • Its Gross Profit stands at $228.1 million for Q4 2025, versus $232.6 million for Q3 2025 and $224.3 million for Q2 2025.